* Streamline Health Solutions Inc STRM.OQ STRM.O is
expected
to show a fall in quarterly revenue when it reports results on
June 6 (estimated).
* The Alpharetta Georgia-based company is expected to
report a
7.4% decrease in revenue to $5.494 million from $5.94 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Streamline
Health
Solutions Inc is $3, above its last closing price of $1.50.
This summary was machine generated June 2 at 11:17 GMT. All
figures in US dollars unless otherwise stated